医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2014年
8期
1508-1510
,共3页
马来酸盐类/治疗应用%柠檬酸盐类/治疗应用%哌啶类/治疗应用%胃肠病用药/治疗应用%胆汁返流/并发症%胃炎/病因学%胃炎/药物疗法%治疗结果
馬來痠鹽類/治療應用%檸檬痠鹽類/治療應用%哌啶類/治療應用%胃腸病用藥/治療應用%膽汁返流/併髮癥%胃炎/病因學%胃炎/藥物療法%治療結果
마래산염류/치료응용%저몽산염류/치료응용%고정류/치료응용%위장병용약/치료응용%담즙반류/병발증%위염/병인학%위염/약물요법%치료결과
Maleates/TU%Citrates/TU%Piperidines/TU%Gastrointestinal Agents/TU%Bile Reflux/CO%Gastritis/ET%Gastritis/DT%T reatment Outcome
【目的】探讨阿嗪米特联合胃肠动力药物莫沙必利对胆汁反流性胃炎患者的治疗效果。【方法】选择本院于2011年12月至2013年12月接诊的120例胆汁反流性胃炎患者的临床病例资料,将所有接诊患者按随机数字表分为对照组60例患者,采用碳酸铝镁联合莫沙必利治疗,观察组60例患者,采用阿嗪米特联合莫沙必利治疗,比较两组患者的治疗效果。【结果】治疗后,观察组患者的总有效率为86.67%,明显高于对照组患者66.67%,组间差异具有统计学意义( P <0.05);观察组患者的症状评分均较对照组患者治疗前明显改善,组间差异均具有明显统计学意义( P <0.05);观察组患者的胆汁反流次数和最长反流时间等均明显低于对照组患者,组间差异具有明显统计学意义( P <0.05)。【结论】阿嗪米特与胃肠动力药物莫沙必利联合应用,可通过协同治疗作用,不但促进胆汁规律性地分泌,而且增加胃肠运动,促进食物消化能力,改善患者的临床不适症状,有利于患者病情改善和生活质量的提高,值得临床推广应用。
【目的】探討阿嗪米特聯閤胃腸動力藥物莫沙必利對膽汁反流性胃炎患者的治療效果。【方法】選擇本院于2011年12月至2013年12月接診的120例膽汁反流性胃炎患者的臨床病例資料,將所有接診患者按隨機數字錶分為對照組60例患者,採用碳痠鋁鎂聯閤莫沙必利治療,觀察組60例患者,採用阿嗪米特聯閤莫沙必利治療,比較兩組患者的治療效果。【結果】治療後,觀察組患者的總有效率為86.67%,明顯高于對照組患者66.67%,組間差異具有統計學意義( P <0.05);觀察組患者的癥狀評分均較對照組患者治療前明顯改善,組間差異均具有明顯統計學意義( P <0.05);觀察組患者的膽汁反流次數和最長反流時間等均明顯低于對照組患者,組間差異具有明顯統計學意義( P <0.05)。【結論】阿嗪米特與胃腸動力藥物莫沙必利聯閤應用,可通過協同治療作用,不但促進膽汁規律性地分泌,而且增加胃腸運動,促進食物消化能力,改善患者的臨床不適癥狀,有利于患者病情改善和生活質量的提高,值得臨床推廣應用。
【목적】탐토아진미특연합위장동력약물막사필리대담즙반류성위염환자적치료효과。【방법】선택본원우2011년12월지2013년12월접진적120례담즙반류성위염환자적림상병례자료,장소유접진환자안수궤수자표분위대조조60례환자,채용탄산려미연합막사필리치료,관찰조60례환자,채용아진미특연합막사필리치료,비교량조환자적치료효과。【결과】치료후,관찰조환자적총유효솔위86.67%,명현고우대조조환자66.67%,조간차이구유통계학의의( P <0.05);관찰조환자적증상평분균교대조조환자치료전명현개선,조간차이균구유명현통계학의의( P <0.05);관찰조환자적담즙반류차수화최장반류시간등균명현저우대조조환자,조간차이구유명현통계학의의( P <0.05)。【결론】아진미특여위장동력약물막사필리연합응용,가통과협동치료작용,불단촉진담즙규률성지분비,이차증가위장운동,촉진식물소화능력,개선환자적림상불괄증상,유리우환자병정개선화생활질량적제고,치득림상추엄응용。
To explore the clinical efficacy of azintamide combined with gastrointestinal motili-ty drug mosapride for the treatment of bile reflux gastritis .[Methods]Totally 120 patients with bile reflux gastritis in our hospital from Dec .2011 to Dec .2013 were selected and randomly divided into control group ( n=60) treated with aluminum magnesium carbonate and mosapride and the observation group ( n=60) treated with azintamide and mosapride .Clinical efficacy was compared between two groups .[Results] After treat-ment ,the total effective rate in observation group was 86 .67% ,which was significantly higher than that in control group ,and there was significant difference between two groups ( P < 0 .05) .Compared with control group ,the symptom scores in observation group were obviously improved ,and there was significant difference between two groups( P < 0 .05) .The frequency of bile reflux and most general reflux time in observation group were obviously lower than those in control group ,and there was significant difference ( P < 0 .05) .[Conclusion] Azintamide combined with gastrointestinal motility drug mosapride can not only promote regular bile secretion ,but also increase gastrointestinal motility and food digest ability ,improve clinical uncomfortable symptoms and is helpful for the improvement of pathogenetic condition and quality of life through the synergis-tic effect .Therefore ,it is worthy of clinical application .